NCT04530721

Brief Summary

Stroke is a common clinical disease with high disability and mortality, which seriously threatens human life and health.Carotid atherosclerotic plaque rupture is an important pathogenic basis of ischemic stroke, so judging the stability of plaque has important clinical significance in preventing ischemic stroke.Ultrasound, as a convenient, rapid, noninvasive, radiation-free auxiliary examination technology, is widely used in carotid plaque stability examination.At present, there are many methods to judge the stability of carotid plaque based on ultrasound, including two-dimensional ultrasound, contrast-enhanced ultrasound, ultrasound elastography and so on. However, the results of plaque stability judgment by various technologies deviate greatly, which is not conducive to the development of standardized diagnosis and treatment strategies by clinicians.Studies have shown that because the neovascular epidermal cells in atherosclerotic plaques are imperfect, they are easy to rupture after stress, and the ruptured neovasculature will lead to intraplaque hemorrhage, thus causing plaque shedding, and eventually obstructing the cerebrovascular cause stroke.Contrast-enhanced ultrasound can sensitively detect the distribution and course of blood vessels.The plaque's softness and hardness determine its stability, while the difference of lipids, fibers and calcium in the plaque determines its softness and hardness.Real-time ultrasound elastography can provide tissue mechanical parameters, express the soft and hard of tissue with strain value, and provide important reference information for judging plaque stability.At present, elastography technology is used to reflect the hardness of plaque, so as to further judge its stability.However, the elastography parameters are prone to deviations due to the influence of the selected section and the selected region of interest.It can be seen from the above that there is currently a multi-modality method to evaluate the stability of carotid plaque using ultrasound, but there is a lack of a unified and objective reference standard for plaque stability assessment.The purpose of this study is to explore the comprehensive utilization of these modalities under the premise of optimizing each ultrasound modality to provide a unified and objective criterion for judging the stability of carotid plaque.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2020

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

June 26, 2020

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 28, 2020

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

August 28, 2020

Status Verified

June 1, 2020

Enrollment Period

1.9 years

First QC Date

June 26, 2020

Last Update Submit

August 27, 2020

Conditions

Keywords

ultrasound

Outcome Measures

Primary Outcomes (1)

  • Accuracy of carotid plaque stability assessment criteria based on ultrasound multimodality Technology

    Conventional ultrasound,CEUS,

    2 years

Study Arms (2)

stroke group

Other: no intervention

normal group

Other: no intervention

Interventions

we don't do any intervention

normal groupstroke group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Outpatient and inpatient patients with carotid plaque in our hospital

You may qualify if:

  • At least one examination suggested the presence of carotid plaque
  • Suitable for CEUS examination
  • Voluntary enrollment in this study and signing of informed consent

You may not qualify if:

  • Among ischemic brain rates caused by non-carotid plaque shedding
  • Follow-up Lost
  • Pregnant women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Second Affiliated Hospital,School of Medicine, Zhejiang University

Hangzhou, Zhejiang, 310000, China

RECRUITING

MeSH Terms

Conditions

Arteriosclerosis

Condition Hierarchy (Ancestors)

Arterial Occlusive DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Ying Zhang, Master

    Ultrasound Department

    PRINCIPAL INVESTIGATOR
  • Guoqiang Mo, Master

    Ultrasound Department

    STUDY DIRECTOR

Central Study Contacts

Pintong Huang, PHD

CONTACT

Tao Jiang, Master

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 26, 2020

First Posted

August 28, 2020

Study Start

January 1, 2020

Primary Completion

December 1, 2021

Study Completion

December 31, 2021

Last Updated

August 28, 2020

Record last verified: 2020-06

Locations